Variant report
Variant | esv3406879 |
---|---|
Chromosome Location | chr14:66261593-66262062 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr14:65877493..65879893-chr14:66259513..66261603,2 | MCF-7 | breast: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FUT8-3 | chr14:66261740-66262033 | NONHSAT037398 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000033170 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529340430 | chr14:66261611-66261612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535623633 | chr14:66261619-66261620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs56165076 | chr14:66261620-66261621 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs189668646 | chr14:66261694-66261695 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183267441 | chr14:66261699-66261700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs574978991 | chr14:66261709-66261710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs386778389 | chr14:66261711-66261712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs55760239 | chr14:66261712-66261713 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs207474922 | chr14:66261747-66261748 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs187548650 | chr14:66261759-66261760 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs557029186 | chr14:66261781-66261782 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs577488944 | chr14:66261782-66261783 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs533967637 | chr14:66261823-66261824 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs150945867 | chr14:66261889-66261890 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs141969813 | chr14:66261890-66261891 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs8018379 | chr14:66261937-66261938 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs192182830 | chr14:66261957-66261958 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs183535496 | chr14:66262026-66262027 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 22032731 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17603634 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 23393157 | CNVD |
Schizophrenia | 23393157 | CNVD |
Seizures | 23393157 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:66258600-66265600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr14:66258800-66268800 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr14:66259400-66261600 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr14:66259400-66265000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
5 | chr14:66261200-66262000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr14:66261400-66261600 | Enhancers | Gastric | stomach |
7 | chr14:66261600-66261800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr14:66261600-66262600 | Weak transcription | Gastric | stomach |